Medomeksi
Medomeksi - Pharmaceutical Company Promo-Med notifies about the product “Medomeksi” release on Russian pharmaceutical market in March 2010. This product (international generic/unlicensed name - etilmetilgidroksipiridina succinate) is a solution for intravenous and intramuscular injection. The form of release - 2 ml vials and 5 ml.
Pharmacological effects of product Medomeksi:
Antioxidant
Stress-protective
Antihypoxic
Metabolic
Anti-ischemic
Cytoprotective
Antiatherogenic
Vegetotropic
Detoxification
Anti-platelet
Vazotropic
Anxiolytic